Celgene (CELG) – ETFs
-
Stocks hit record as senators reach deal to end shutdown
-
Wall Street slips heading into holiday
-
Wall Street ends higher with help from tech, energy
-
Dow, S&P gain but Nasdaq dips as healthcare lags
-
When it comes to U.S. stocks, growth trumps quality
-
Biotech Stocks Show Strength (IBB)
-
Celgene (CELG), Biotech Peers Pressured on Market Open
-
Biotech Stocks Surge on Trump Victory (XBI) (IBB)
-
Biotechs Continue to Underperform (IBB)
-
Biotech Stocks Pressured (BIIB) (CELG) (GILD)
-
iShares Nasdaq Biotechnology (IBB) Poised to Open Up Over 2%
-
Wall Street Looks to Soothe Biotech's Holiday Meltdown (GILD) (CELG) (AMGN)
-
Celgene (CELG), Related Stocks Decline Amid Biopharma Weakness
-
Biotech ETF Sees Upside; Related Names Higher (GILD) (CELG) (BIIB) (AMGN)
-
Biotech Stocks Pressured, Again (IBB)
-
Biotech Correction Nearing Support - Wells Fargo Survey (GILD) (CELG) (VRTX) (PCYC) (ITMN) (FPRX) (ARRY) (IBB)
-
Bears Beaten Back as Markets Wake Up to Oversold Conditions
-
Notable ETF Movers of the Day 02/06: (XME) Higher; (OIH) (IBB) Lower
-
Buy Apple (AAPL) Sell S&P 500 (SPY), Says Carter Worth
-
Notable ETF Movers of the Day 11/12: (IBB) Higher; (XLU) (ITB) Lower
Back to CELG Stock Lookup